Get the Stockscreener App
708.45
0.74%
-5.29
After Hours:
708.45
Idexx Laboratories Inc stock is traded at $708.45, with a volume of 409.86K.
It is down -0.74% in the last 24 hours and up +12.94% over the past month.
Idexx Laboratories primarily develops, manufactures, and distributes diagnostic products, equipment, and services for pets and livestock. Its key product lines include single-use canine and feline test kits that veterinarians can employ in the office, benchtop chemistry and hematology analyzers for test-panel analysis on-site, reference lab services, and tests to detect and manage disease in livestock. The firm also offers vet practice management software and consulting services to animal hospitals. Idexx gets close to 35% of its revenue from outside the United States.
See More
Previous Close:
$713.74
Open:
$710.15
24h Volume:
409.86K
Relative Volume:
0.88
Market Cap:
$56.68B
Revenue:
$4.17B
Net Income/Loss:
$1.03B
P/E Ratio:
56.16
EPS:
12.6148
Net Cash Flow:
$940.22M
1W Performance:
+12.54%
1M Performance:
+12.94%
6M Performance:
+45.59%
1Y Performance:
+63.61%
1-Day Range:
$700.20
$716.71
1-Week Range:
$691.73
$735.00
52-Week Range:
$356.14
$735.00
Idexx Laboratories Inc Stock (IDXX) Company Profile
Name
Idexx Laboratories Inc
Sector
Industry
Phone
(207) 556-0300
Address
ONE IDEXX DRIVE, WESTBROOK, ME
Compare IDXX with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
708.45 | 56.99B | 4.17B | 1.03B | 940.22M | 12.61 |
|
TMO
Thermo Fisher Scientific Inc
|
572.41 | 212.64B | 43.74B | 6.58B | 6.11B | 17.31 |
|
DHR
Danaher Corp
|
209.94 | 148.81B | 24.27B | 3.50B | 5.02B | 4.8589 |
|
A
Agilent Technologies Inc
|
146.74 | 41.81B | 6.79B | 1.22B | 1.09B | 4.2644 |
|
IQV
Iqvia Holdings Inc
|
210.46 | 35.91B | 15.90B | 1.28B | 2.21B | 7.2842 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Oct-31-25 | Upgrade | Stifel | Hold → Buy |
| Oct-01-25 | Initiated | UBS | Neutral |
| Aug-05-25 | Reiterated | BTIG Research | Buy |
| Jul-01-25 | Initiated | Jefferies | Buy |
| Dec-02-24 | Initiated | Leerink Partners | Outperform |
| Jul-25-24 | Initiated | BTIG Research | Buy |
| Jan-30-24 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-07-23 | Initiated | Exane BNP Paribas | Outperform |
| Dec-04-23 | Upgrade | Cleveland Research | Neutral → Buy |
| Aug-02-23 | Downgrade | Atlantic Equities | Overweight → Neutral |
| Jul-25-22 | Downgrade | Stifel | Buy → Hold |
| Jul-21-22 | Upgrade | Goldman | Neutral → Buy |
| Jul-12-22 | Initiated | Piper Sandler | Overweight |
| May-05-22 | Downgrade | BofA Securities | Buy → Neutral |
| Feb-08-22 | Initiated | Atlantic Equities | Overweight |
| Nov-18-21 | Initiated | Morgan Stanley | Overweight |
| Aug-05-21 | Resumed | Credit Suisse | Outperform |
| Jul-12-21 | Downgrade | Guggenheim | Buy → Neutral |
| Feb-17-21 | Initiated | Barclays | Overweight |
| Sep-09-19 | Initiated | Goldman | Neutral |
| May-23-19 | Initiated | Guggenheim | Buy |
| Nov-02-18 | Reiterated | BofA/Merrill | Buy |
| May-07-18 | Reiterated | Stifel | Buy |
| Jan-16-18 | Initiated | Piper Jaffray | Overweight |
| Aug-23-17 | Upgrade | BofA/Merrill | Neutral → Buy |
| Jul-28-17 | Upgrade | CL King | Neutral → Buy |
| Feb-03-17 | Downgrade | Feltl & Co. | Hold → Sell |
| Sep-29-16 | Resumed | BofA/Merrill | Neutral |
| Aug-16-16 | Reiterated | Stifel | Buy |
| Aug-03-16 | Upgrade | Northcoast | Sell → Neutral |
| Jul-20-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-19-16 | Reiterated | Canaccord Genuity | Buy |
| Apr-01-16 | Initiated | CL King | Neutral |
| Mar-21-16 | Reiterated | Stifel | Buy |
| Feb-04-16 | Initiated | Credit Suisse | Outperform |
| Oct-29-15 | Reiterated | Stifel | Buy |
| Aug-28-15 | Downgrade | Raymond James | Outperform → Mkt Perform |
| Aug-13-15 | Reiterated | Stifel | Buy |
| Jul-23-15 | Reiterated | Canaccord Genuity | Buy |
View All
Idexx Laboratories Inc Stock (IDXX) Latest News
Does IDEXX Laboratories Inc. fit your quant trading modelWeekly Stock Summary & Risk Adjusted Buy and Sell Alerts - newser.com
Building trade automation scripts for IDEXX Laboratories Inc.2025 Biggest Moves & Precise Buy Zone Identification - newser.com
Quantitative breakdown of IDEXX Laboratories Inc. recent moveOptions Play & Free Growth Oriented Trading Recommendations - newser.com
IDEXX Laboratories Hits Day High with 14.84% Surge in Stock Price - Markets Mojo
Will IDEXX Laboratories Inc. stock recover after recent drop2025 Macro Impact & Low Drawdown Momentum Ideas - newser.com
Why IDEXX Laboratories (IDXX) Is Up 13.6% After Strong Q3 Results and Raised 2025 Guidance - Yahoo Finance
Earnings Beat: IDEXX Laboratories, Inc. Just Beat Analyst Forecasts, And Analysts Have Been Updating Their Models - Yahoo Finance
Will earnings trigger a reversal in IDEXX Laboratories Inc.2025 Growth vs Value & Reliable Breakout Forecasts - newser.com
Agree To Buy Idexx Laboratories At $600, Earn 5.3% Annualized Using Options - Nasdaq
Here’s Why Baron Focused Growth Fund Invested in IDEXX Laboratories (IDXX) - Insider Monkey
Is IDEXX Laboratories Inc. stock a safe buy before earningsJuly 2025 Earnings & Technical Buy Zone Confirmations - newser.com
Why retail investors favor IDEXX Laboratories Inc. stockEarnings Performance Report & Free Community Supported Trade Ideas - newser.com
Is IDEXX Laboratories Inc. stock ready for a breakoutTrade Ideas & Daily Stock Momentum Reports - newser.com
IDEXX Laboratories Hits New 52-Week High of $734.64, Up 42.24% - Markets Mojo
IDEXX Laboratories (NASDAQ:IDXX) Price Target Raised to $775.00 - MarketBeat
Blue Barn Wealth LLC Takes $225,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Jacobson & Schmitt Advisors LLC Grows Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Bridgewater Advisors Inc. Takes Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
415 Shares in IDEXX Laboratories, Inc. $IDXX Acquired by Fullcircle Wealth LLC - MarketBeat
Bank of Montreal Can Boosts Stock Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
Arkadios Wealth Advisors Acquires New Shares in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX outlines 9.6%–10.3% revenue growth outlook for 2025 amid robust CAG Diagnostics expansion - MSN
Trend analysis for IDEXX Laboratories Inc. this week2025 Risk Factors & Reliable Breakout Forecasts - newser.com
IDEXX Laboratories Inc. (IDXX) Stock Price | Live Quotes & Charts | NASDAQ - StocksToTrade
UBS Maintains IDEXX Laboratories (IDXX) Neutral Recommendation - Nasdaq
Idexx Laboratories (IDXX) Just Flashed Golden Cross Signal: Do You Buy? - sharewise.com
Idexx Laboratories (IDXX) Just Overtook the 50-Day Moving Average - sharewise.com
Analysts Offer Insights on Healthcare Companies: Kymera Therapeutics (KYMR), Cullinan Management (CGEM) and Idexx Laboratories (IDXX) - The Globe and Mail
IDEXX Laboratories (IDXX) Sees Target Price Raised by Morgan Sta - GuruFocus
3 Reasons Why Growth Investors Shouldn't Overlook Idexx (IDXX) - Yahoo Finance
Morgan Stanley Maintains IDEXX Laboratories Inc(IDXX.US) With Buy Rating, Raises Target Price to $805 - 富途牛牛
UBS Maintains IDEXX Laboratories Inc(IDXX.US) With Hold Rating, Raises Target Price to $750 - 富途牛牛
UBS Adjusts Price Target on IDEXX Laboratories to $750 From $710, Maintains Neutral Rating - MarketScreener
IDEXX Laboratories (NASDAQ:IDXX) Hits New 12-Month High Following Earnings Beat - MarketBeat
World Investment Advisors Takes $456,000 Position in IDEXX Laboratories, Inc. $IDXX - MarketBeat
IDEXX Laboratories (NASDAQ:IDXX) Releases FY 2025 Earnings Guidance - MarketBeat
Idexx Laboratories stock reaches 52-week high at $693.00 By Investing.com - Investing.com Australia
IDEXX Laboratories (NASDAQ:IDXX) Posts Quarterly Earnings Results, Beats Estimates By $0.26 EPS - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Q3 2025 Earnings Call Transcript - Insider Monkey
Bank of New York Mellon Corp Raises Holdings in IDEXX Laboratories, Inc. $IDXX - MarketBeat
A Fresh Look at IDEXX Laboratories (IDXX) Valuation After Raising Full-Year Growth Outlook - Yahoo Finance
Meta Platforms, S&P Global And A Health Care Stock: CNBC's 'Final Trades' - Benzinga
A Quick Look at Today's Ratings for IDEXX Laboratories Inc(IDXX.US), With a Forecast Between $775 to $830 - 富途牛牛
Fund Update: 16,825 IDEXX LABS (IDXX) shares added to KEYBANK NATIONAL ASSOCIATION|OH portfolio - Quiver Quantitative
Jefferies Adjusts Price Target on IDEXX Laboratories to $830 From $785, Maintains Buy Rating - MarketScreener
Morgan Stanley Adjusts Price Target on IDEXX Laboratories to $805 From $765, Maintains Overweight Rating - MarketScreener
JPMorgan Adjusts Price Target on IDEXX Laboratories to $775 From $675, Maintains Overweight Rating - MarketScreener
BTIG Adjusts Price Target on IDEXX Laboratories to $830 From $785, Maintains Buy Rating - MarketScreener
BNP Paribas Exane Adjusts Price Target on IDEXX Laboratories to $823 From $761, Maintains Outperform Rating - MarketScreener
Rothschild & Co Redburn Adjusts PT on IDEXX Laboratories to $700 From $670, Maintains Neutral Rating - MarketScreener
Why Analysts See the IDEXX Story Shifting With Upgraded Forecasts and Improved Growth Momentum - Yahoo Finance
Idexx Laboratories Inc Stock (IDXX) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.51%
0.55%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):